BPC-157 vs Zinc-L-carnosine
Written by Aaron CuhaReviewed Sep 2026
The short answer
Two products sold for the gut lining with very different records with regulators. Zinc-L-carnosine is an approved prescription stomach medicine in Japan. It has a large final stage trial in trouble swallowing caused by radiation treatment. BPC-157 is not approved anywhere.
- BPC-157 people
- 31
- BPC-157 nulls
- 1
- Zinc-L-carnosine people
- 0
- Zinc-L-carnosine nulls
- 0
Dose
No human dose established
No published study has given BPC-157 as a shot under the skin or as a pill, the ways most buyers take it. Amounts that circulate in forums are not a human dose. Amounts that were given in studies sit in Human evidence on this page.
Commonly reported amounts, in mcg. BPC-157 has no approved label and no completed human dosing trial.
Amounts commonly reported by people buying BPC-157, recorded for this archive's reconstitution calculator, are 250, 500 and 750 mcg. They are self-reports rather than trial doses, and this archive does not recommend any of them. No human dose has been established for BPC-157.
| Reported amount | Where the number comes from |
|---|---|
| 250 mcg | Commonly reported, no published human dosing trial |
| 500 mcg | Commonly reported, no published human dosing trial |
| 750 mcg | Commonly reported, no published human dosing trial |
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
1 completed trial, 0 people given it
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
BPC-157Body Protection Compound 157
A lab-made piece of a stomach protein. It has lots of animal studies on tendon, muscle and gut healing. In people there is very little: two enema studies in Croatia, three small clinic reports with nobody to compare against, and one injury study with a dummy group that is still signing people up.
Column B
Zinc-L-carnosineZinc-L-carnosine (polaprezinc), zinc and carnosine chelate
In a final-stage trial in women having radiotherapy for breast cancer, it prevented trouble swallowing. It is a mix of zinc and a small peptide, approved as a stomach drug in Japan and sold as a supplement in the US.
Side by side, on the facts we can check
| What we compare | BPC-157 | Zinc-L-carnosine |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| FDA status | Not FDA-approved. In April 2026 the FDA took it off Category 2, its list of pharmacy ingredients with safety worries. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with one member abstaining, in favor of letting pharmacies make it. The FDA's own reviewers had advised against that. The FDA has not acted yet | Not an FDA-approved drug. Sold as a dietary supplement in the United States. In Japan it is an approved prescription stomach medicine, sold there since 1994. |
| Half-life | Under 30 minutes in plasma in a two-person pilot; the animal literature describes effects lasting hours to days. | Not meaningfully described as a chelate, because its intended action is local adhesion to mucosa and local zinc release rather than systemic exposure. |
| Molecular weight | 1,419.5 Da | Roughly 289 Da for the zinc and L-carnosine complex. |
| How it works | In animals, BPC-157 helps grow new blood vessels. It works with nitric oxide, a gas the body uses to widen blood vessels. In tendon cells from animals, it raises growth hormone receptors and growth signals. Nobody has found the exact switch it acts on. The FDA's 2026 review gave that as one reason it could not judge whether it should work. In people, very little is known. After an enema, it could not be found in the blood. A two-person test suggests it leaves the blood in under 30 minutes. Animal studies describe effects that last hours to days. | Zinc-L-carnosine is one zinc locked onto one L-carnosine. The pair sticks mainly to sore, inflamed or ulcerated gut lining. There it comes apart and releases zinc right on the spot, at a higher level than a zinc pill would reach. Zinc helps repair the lining, steadies cell walls and boosts antioxidant defence, by raising a protein called metallothionein. Carnosine is an antioxidant itself and grabs loose metals. In a dish and in animals, it speeds up the lining cells moving in to close a wound, and it raises protective heat shock proteins. Its actions are mostly local to the lining. That is why the evidence is about gut and lining injury, not effects around the body. |
| Studies in people | 7 | 1 |
| Evidence | Limited: 3 completed trials, 31 people given it | Limited: 1 completed trial, none stating how many people |
| Legal status, US | Not approved; research use only | Sold as a supplement |
Frequently asked questions
What is the difference between BPC-157 and Zinc-L-carnosine?
BPC-157: A lab-made piece of a stomach protein. It has lots of animal studies on tendon, muscle and gut healing. In people there is very little: two enema studies in Croatia, three small clinic reports with nobody to compare against, and one injury study with a dummy group that is still signing people up. Zinc-L-carnosine: In a final-stage trial in women having radiotherapy for breast cancer, it prevented trouble swallowing. It is a mix of zinc and a small peptide, approved as a stomach drug in Japan and sold as a supplement in the US.
Which has stronger research evidence, BPC-157 or Zinc-L-carnosine?
Each compound gets a band worked out from facts we counted, with the math shown. BPC-157 is Limited (3 completed trials, 31 people given it). Zinc-L-carnosine is Limited (1 completed trial, none stating how many people). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are BPC-157 and Zinc-L-carnosine FDA-approved?
BPC-157: Not FDA-approved. In April 2026 the FDA took it off Category 2, its list of pharmacy ingredients with safety worries. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with one member abstaining, in favor of letting pharmacies make it. The FDA's own reviewers had advised against that. The FDA has not acted yet. Zinc-L-carnosine: Not an FDA-approved drug. Sold as a dietary supplement in the United States. In Japan it is an approved prescription stomach medicine, sold there since 1994..
Related posts
Blog articles that cover BPC-157 or Zinc-L-carnosine, newest first.
- Healing & Recovery / Sep 27, 2026 / 9 minPeptides for Joint Pain: BPC-157, TB-500, Lorecivivint, Pentosan and Collagen Peptides, Evidence Tiered
- Healing & Recovery / Sep 27, 2026 / 8 minPeptides for Gut Health: BPC-157, KPV and Larazotide Ranked by Human Evidence
- Safety / Sep 27, 2026 / 9 minPeptide Side Effects by Class: What Is Documented, What Is Anecdotal
- Safety / Sep 27, 2026 / 8 minHow to Read a Peptide Certificate of Analysis: HPLC Purity, Mass Spec Identity, Endotoxin, and Janoshik Verification
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.